nonnucleoside hepatitis C virus polymerase inhibitor +
nonstructural protein 5A inhibitor +
oxidative phosphorylation inhibitor +
parthenolide +
PCNA inhibitor +
phospholipid biosynthesis inhibitor +
quinol oxidation site inhibitor +
quorum sensing inhibitor +
Rac1 inhibitor +
RhoA inhibitor +
RhoC inhibitor +
RUNX1 inhibitor +
S100 calcium-binding protein B inhibitor +
secreted frizzled-related protein 1 inhibitor +
signal transducer and activator of transcription 5 protein inhibitor +
Smad3 inhibitor +
sodium-dependent Pi-transporter inhibitor +
sodium-glucose transport protein subtype 2 inhibitor +
STAT3 inhibitor +
sterol biosynthesis inhibitor +
succinyl-CoA
T-cell proliferation inhibitor +
tau aggregation inhibitor +
A chemical that inhibits the aggregation of the tau protein (HGNC:MAPT) and its distinct morphological forms (e.g. paired helical fragments (PHFs), straight filaments (SFs), oligomers, or larger aggregates).